AAO 2023: Paul Runge speaks about treating retinopathy of prematurity in Ukraine

News
Video

At the 2023 AAO meeting, Paul Runge, MD, FACS, spoke with Ophthalmology Times about his time in Ukraine treating retinopathy of prematurity (ROP) and implementing the Norlase Lion laser at this year's American Academy of Ophthalmology meeting.

Paul Runge, MD, FACS, spoke with Ophthalmology Times at this year's American Academy of Ophthalmology meeting, discussing his time in Ukraine treating retinopathy of prematurity (ROP) and the process of implementing the Norlase LION laser.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Paul Runge, MD, FACS:

Hello, I'm Dr Paul Runge. I've been working in western Ukraine over the last year and a half at a children's hospital, primarily with treating retinopathy of prematurity. We have introduced the new Norlase LION laser, which has made a dramatic improvement in the way this condition is treated in Ukraine. The Norlase LION is the first laser of its type to be deployed in Ukraine. And we treated 3 babies last week, and the ophthalmologist I worked [with] there, Tetyana [Gavrylyshyn, MD], who's a paediatric ophthalmologist, she said that it was the best treatment she has ever seen and that the baby we treated would most likely not have responded if we had used the previous laser she had been using. So it's made a remarkable change.

Over the last 3 years, she has been using an 810 nanometer red laser, and now we've shifted to, over the last 6 months, the Norlase diode 522 green laser. So, we've been really extremely happy with not only the results, but what we've been what we've been able to accomplish. The other thing I've done with the laser is we've been teaching medical students how to use it, how to use an indirect ophthalmoscope and just to give them something practical to do, so it's been a lot of fun for them, and I was able to demonstrate the laser for about 150 medical students, fourth year medical students. So, it's been a remarkable experience, and I just returned from the Ukraine a few days ago, and I'll be going back in about a month. So you know, appreciate everybody's support for the Ukraine. We're still struggling, and we can use all the help we can get. Thank you very much.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.